Market News
7 min read | Updated on September 20, 2024, 14:02 IST
SUMMARY
On Friday, the NIFTY50 index traded above the level of 25,650. Cochin Shipyard hit the 10% upper circuit while Heritage Foods, Unitech and Reliance Power hit a 5% upper circuit. GE T&D India, Panacea Biotec and MIC Electronics hit a 5% lower circuit.
Cochin Shipyard, Heritage Foods, Unitech and Reliance Power hit the upper circuit, while GE T&D India, Panacea Biotec and MIC Electronics hit the lower circuit today
Domestic equity bourses, NIFTY50 and SENSEX are trading in the green, advancing by 0.99% and 1.05%, respectively. Nifty Midcap 100 index and the Nifty Smallcap 100 index are trading positively, up by 0.72% and 0.84% respectively.
On the NSE, 73 stocks hit the upper price band (Upper Circuit), and 20 stocks hit the lower price band (Lower Circuit).
Here is the list of stocks (market cap above ₹1,000 crore) locked in upper and lower circuits in today’s trading session.
Additionally, Global index provider FTSE unveiled inclusions to its All-World Index in its Semiannual Index Review. These changes are slated to come into effect on September 23, 2024. 13 Indian stocks have been added to the FTSE All-World Index and Cochin Shipyard is one of the stocks which is going to be added.
The company is a leading player in the construction of all types of vessels, and performing repairs, refits, periodic upgrades, and life extensions of ships. It has a market capitalisation of ₹48,300 crore.
Heritage Foods is engaged in the business of procurement and processing of milk and milk products and also the generation of power through solar and wind for the captive consumption of its dairy plants. The company has a market capitalisation of ₹5,530 crore and over the past one year company shares have surged by 150%.
The company has a market capitalisation of ₹2,700 crore and over the past one year company shares have surged by 247%.
Reliance Infrastructure, which held a 23.15% stake in Reliance Power as of June 30, advanced by 45% over the last one week. Reliance Power has been established to develop, construct and operate power projects in India and internationally. The company has a market capitalisation of ₹14,600 crore and over the past six months company shares have surged by 53%.
The floor price of the offer will be ₹1,400 per equity share. The OFS involves up to 11.7% of the company’s equity share capital, which amounts to 30 million shares. Each share has a face value of ₹2. The promoters have also included an oversubscription option to sell an additional 3.9% of equity, representing 10 million shares, which could increase the total sale to 15.6% of the company’s paid-up equity share capital, if fully exercised. This means the total potential offer size could reach 40 million shares.
GE T&D India is the entity of GE Vernova’s Electrification business in India. It has been in the power transmission and distribution business for more than 100 years and provides a versatile range of solutions for connecting and evacuating power from generation sources onto the grid. It has a market capitalisation of ₹41,000 crore.
Panacea Biotec is a global pharmaceutical and vaccine manufacturer based in New Delhi, Mumbai, and Lalru. The company researches, develops, manufactures, and markets pharmaceuticals, vaccines, biosimilars, and natural products.
Over the past three months, the company's shares have surged as currently India lacks an antiviral treatment or licensed vaccine for dengue. Panacea Biotec is working on a dengue vaccine, which has been in development since 2006. In March 2022, the company partnered with the Indian Council of Medical Research (ICMR) for this project. On August 14, Panacea Biotec commenced Phase-3 trials for its Tetravalent Dengue Vaccine, DengiALL, in India. Approved by the Drug Controller General of India (DCGI), these trials involve 10,335 participants across 19 sites and represent the first Phase-3 clinical trial for a dengue vaccine in India.
Additionally, the company recently announced the settlement of a legal dispute with Sanofi Healthcare India Private Limited (Sanofi). On May 17, 2021, Panacea Biotec filed a lawsuit in the Delhi High Court to prevent Sanofi from marketing a fully liquid hexavalent vaccine that would infringe on Panacea’s patent for its wP-IPV based fully liquid hexavalent vaccine, EasySix. Under the settlement, Sanofi has agreed not to launch its fully liquid hexavalent vaccine Shan6 in India commercially and will withdraw its opposition to Panacea Biotec’s Patent IN 272351 on the hexavalent vaccine before the Indian Patent Office. The company has a market capitalisation of ₹1,900 crore.
MIC Electronics is a global leader in the design, development and manufacturing of LED Video Displays, high-end Electronic and Telecommunication equipment and development of Telecom software since 1988. The company has a market capitalisation of ₹2,300 crore.
About The Author
Next Story